Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) insider Matthew E. Korenberg sold 3,440 shares of Ligand Pharmaceuticals stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $84.54, for a total value of $290,817.60. Following the sale, the insider now directly owns 100,421 shares in […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) insider Matthew E. Korenberg sold 3,440 shares of the company’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $84.54, for a total transaction of $290,817.60. Following the sale, the insider now directly owns 100,421 shares of the company’s […]